Notícias de: Multidisciplinary meeting

The Mário Penna Institute’s Medical Residency Committee (COREME) has been holding virtual Multidisciplinary Meetings with the aim of promoting discussions of clinical cases attended at the institution and, thus, providing the physicians with updates.

According to Dr. Ellias Lima, oncologist and Coordinator of COREME, the objective is to bring the clinical staff together, promote medical residency, plan treatments in a multidisciplinary way, update and promote knowledge.

The meeting is online on a remote digital platform and involves resident physicians, assistant physicians and preceptors. They take place once a month, with educational support from the pharmaceutical industry.

The last meeting took place on April 9th, with the theme “Update on the treatment of Small Cell Lung Cancer”, with the collaboration of the Astrazeneca Laboratory.

Instituto Mário Penna invests in the improvement of its clinical staff to increasingly provide a humanized, recognized and excellent service to its thousands of cancer patients.

The Mário Penna Institute’s Medical Residency Committee (COREME) has been holding virtual Multidisciplinary Meetings with the aim of promoting discussions of clinical cases attended at the institution and, thus, providing the physicians with updates.

According to Dr. Ellias Lima, oncologist and Coordinator of COREME, the objective is to bring the clinical staff together, promote medical residency, plan treatments in a multidisciplinary way, update and promote knowledge. The meeting is online on a remote digital platform and involves resident physicians, assistant physicians and preceptors. They take place once a month, with educational support from the pharmaceutical industry.

The last meetings were on the following topics:

– 07/27: “Polytreated castration-resistant metastatic prostate cancer, state of the art in 2021, with the participation of Dr. Ellias Lima (Oncology Coordinator at IMP), Dr. Ana Carolina Pimenta (Oncologist at IMP) and Dr. Marta Rezende (Nuclear Physician at IMP). The meeting was supported by the Astrazeneca laboratory.

– 04/08: “Update on the treatment of advanced platinum sensitive ovarian cancer”, with the participation of Dr. Bárbara Marques (Clinical Oncologist at IMP), Dr. Suellen Peixoto (Gynecological Surgeon at IMP), Dr. Irsael Vilaça (Oncologist at IMP) and Dr. Oscar Araújo (Diagnostic Coordinator at Astrazeneca). Her meeting was supported by the Astrazeneca laboratory.

Instituto Mário Penna invests in the improvement of its clinical staff to increasingly provide a humanized, recognized and excellent service to its thousands of cancer patients.

The Mário Penna Institute’s Medical Residency Committee (COREME) has been holding virtual Multidisciplinary Meetings with the aim of promoting discussions of clinical cases attended at the institution and, thus, providing the physicians with updates.

According to Dr. Ellias Lima, oncologist and Coordinator of COREME, the objective is to bring the clinical staff together, promote medical residency, plan treatments in a multidisciplinary way, update and promote knowledge.

The meeting is online on a remote digital platform and involves resident physicians, assistant physicians and preceptors. They take place monthly, with educational support from the pharmaceutical industry.

The last meeting was on the following topic:

– 08/24: “Neuroendocrine Tumors”, with the participation of Dr. Renata D´Alpino (Clinical Oncologist at the São Paulo Center of Oncology and Clinical Director of the Brazilian Group of Gastrointestinal Tumors), Dr. Henrique Lins (Oncologist at IMP), Dr. Adelanir Barroso (Nuclear Physician at IMP) and Dr. Mário de Carvalho Filho (Oncology Surgeon at IMP). The meeting was supported by IPSEN.

Instituto Mário Penna invests in the improvement of its clinical staff to increasingly provide a humanized, recognized and excellent service to its thousands of cancer patients.

The Mário Penna Institute’s Medical Residency Committee (COREME) has been holding virtual Multidisciplinary Meetings with the aim of promoting discussions of clinical cases attended at the institution and, thus, providing the physicians with updates.

The meeting is online on a remote digital platform and involves resident physicians, assistant physicians and preceptors. They take place monthly, with educational support from the pharmaceutical industry.

The next meeting takes place this Wednesday, September 15th. The theme is “Asco 2021 Updates on HR+ and HER- Breast Cancer”, with the participation of Dr. Israel Vilaça (Oncologist at IMP); Dr. Rafael Borges (Radiotherapist at IMP); and Dr. Ana Luiza Freitas (Mastologist at IMP. The meeting is supported by the Novartis Laboratory.

“The objective is to bring the clinical staff together, promote medical residency, plan treatments in a multidisciplinary way, update and promote knowledge; explains Dr. Ellias Lima, oncologist and Coordinator of COREME.

Instituto Mário Penna invests in the improvement of its clinical staff to increasingly provide a humanized, recognized and excellent service to its thousands of cancer patients.

Virtual Multidisciplinary Meetings are held monthly by the Medical Residency Committee (COREME) of the Instituto Mário Penna with the aim of promoting discussions of clinical cases attended at the institution and, thus, providing the doctors with updates.

“The objective is to bring the clinical staff together, promote medical residency, plan treatments in a multidisciplinary way, update and promote knowledge”; explains Dr. Ellias Lima, oncologist and Coordinator of COREME.

The meeting is online on a remote digital platform and involves resident physicians, assistant physicians and preceptors. They take place monthly, with educational support from the pharmaceutical industry.

The next meeting will be on the following topic:

– 10/13: “Vaccination in Oncology Patients”, with the participation of Dr. Cláudia Murta (Specialist in Internal Medicine and Infectology at Santa Casa de Belo Horizonte), Dr. Guilherme Luiz Milanez (Infectologist at Instituto Mário Penna) and Dr. Ellias Lima (Oncologist at Instituto Mário Penna).

Instituto Mário Penna invests in the improvement of its clinical staff to increasingly provide a humanized, recognized and excellent service to its thousands of cancer patients.